Closing the Generation Gap: Part 2 - Hemophilia Federation of America
Por un escritor de hombre misterioso
Descripción
Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
NORD and the Galactosemia Foundation Jointly Publish First “Voice of the Patient” Report to Help Inform the FDA and Researchers - National Organization for Rare Disorders
Hemophilia Federation of America on LinkedIn: Join us for our second chat on Dec. 5 where we'll “close the generation…
Interpreting important health-related quality of life change using the Haem-A-QoL – topic of research paper in Health sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Elsa Kendall - EveryLife Foundation for Rare Diseases
Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study - Research and Practice in Thrombosis and Haemostasis
Five key prevention messages.
Diagnostics, Free Full-Text
Federal Register :: Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2024
New Patient Journey Infographic Gives A Glimpse Into The Diagnostic Odyssey - National Organization for Rare Disorders
History of Bleeding Disorders - Hemophilia Federation of America
Are haemophilia gene therapies truly “one and done”?
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial - The Lancet Haematology
Upcoming Events — The Coalition for Hemophilia B
de
por adulto (el precio varía según el tamaño del grupo)